[Phenotypic and molecular characterization of a Colombian family with phenylketonuria]

Nancy Gélvez1, Johana Acosta, Greizy López

  • 1Instituto de Genética Humana, Facultad de Medicina, Pontificia Universidad Javeriana, Bogotá, D.C., Colombia. nancy.gelvez@javeriana.edu.co.

Insights

Early diagnosis of phenylketonuria (PKU) is crucial for preventing severe neurological and behavioral issues. This study characterized a Colombian family with PKU, identifying a specific mutation and highlighting clinical variability.

Area of Science:

  • Genetics
  • Biochemistry
  • Pediatrics

Background:

  • Phenylketonuria (PKU) is a metabolic disorder causing severe neurological and behavioral problems.
  • Early diagnosis and treatment of PKU are essential to prevent long-term sequelae and improve prognosis.
  • Consanguineous families may have a higher incidence of inherited metabolic disorders like PKU.

Purpose of the Study:

  • To conduct a comprehensive clinical, biochemical, and molecular characterization of a Colombian family with phenylketonuria.
  • To identify the specific genetic mutation responsible for PKU in the affected family members.
  • To investigate the genotype-phenotype correlation and understand clinical variability in PKU patients within the family.

Main Methods:

  • Involved seven individuals from a consanguineous family with four children exhibiting PKU symptoms.
  • Utilized colorimetric tests, high-performance liquid chromatography (HPLC), and thin-layer chromatography (TLC) on blood and urine samples.
  • Performed DNA extraction and sequencing of all 13 exons of the Phenylalanine Hydroxylase (PAH) gene, with primer design and sequence analysis using specialized software.

Main Results:

  • Described the clinical and molecular profile of the Colombian PKU family.
  • Confirmed the presence of the specific mutation c.398_401delATCA in affected individuals.
  • Observed significant clinical variability among patients despite sharing the identical PAH gene mutation, indicating complex genotype-phenotype interactions.

Conclusions:

  • Early recognition and management of phenylketonuria are critical for preventing devastating neurological and psychological consequences.
  • Delayed diagnosis can lead to patients reaching adulthood without proper care, resulting in irreversible sequelae.
  • Understanding the genetic basis and clinical presentation of PKU in diverse populations is vital for effective public health strategies.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
972
Pedigree Analysis01:35

Pedigree Analysis

Overview
90.4K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.4K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes01:28

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
86
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
43.8K
Background and Environment Affect Phenotype02:27

Background and Environment Affect Phenotype

Although the genetic makeup of an organism plays a major role in determining the phenotype, there are also several environmental factors, such as temperature, oxygen availability, presence of mutagens, that can alter an organism’s phenotype.
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...
8.0K